Sign in
TerminatedNo phase

Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis

Key facts

Who runs it
Contipro Pharma a.s.
Where
Czechia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
20 people enrolled
Started
23 Oct 2024
Ended
30 Dec 2025
Type of study
Observational
Record updated
24 March 2026
Why it stopped
safety was ok, but efficacy was considered too low - it was decided not to continue woth this study design

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Patients with histologically confirmed rectal adenocarcinoma (< 15 cm from the anal margin) following rectal resection with colorectal anastomosis
  • Patients with or without neoadjuvant therapy
  • Patients willing and able to provide written informed consent
  • Patients able to communicate effectively with the investigator in the local language and to understand and comply with the study requirements

Who cannot take part

  • Subjects with known hypersensitivity or allergy to any component of the investigational product or to the administered antibiotics
  • Acute surgery
  • Other malignancies
  • Age < 18 years
  • Pregnant or breastfeeding women
  • Patients in the terminal stage of life
  • Preventive ostomy
  • Incomplete data

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A two-phase, multicenter, open-label, "first-in-human" prospective study evaluating the product's safety and efficacy in a pivotal phase.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Multi-centre, Open-label, First-in-man Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis Due to Rectal Cancer.
Record updated
24 March 2026